The EURObservational Research Programme (EORP) Registry on Peripartum Cardiomyopathy (PPCM) CPP, Friday, 21th February, Venice

Size: px
Start display at page:

Download "The EURObservational Research Programme (EORP) Registry on Peripartum Cardiomyopathy (PPCM) CPP, Friday, 21th February, Venice"

Transcription

1 The EURObservational Research Programme (EORP) Registry on Peripartum Cardiomyopathy (PPCM) CPP, Friday, 21th February, Venice

2 Long-Term Registry on Patients with Peripartum Cardiomyopathy Executive Committee: Karen Sliwa, Chairperson Burkert Pieske, Chairperson Katrin Bachelier-Walenta Uri Elkayam Roger Hall Denise Hilfiker-Kleiner Aldo Pietro Maggioni John McMurray Alexandre Mebazaa Frederic Mouquet Mark Petrie Piotr Ponikowski Vera Regitz-Zagrosek Jolien Roos-Hesselink Maria Schaufelberger Petar Seferovic Ajay Shah Luigi Tavazzi Karin van Spaendonck-Zwart Dirk van Veldhuisen Coordinating Centre: EURObservational Research Programme 2035 Route des Colles Les Templiers, BP Sophia Antipolis France Tel: +33(0) Fax: +33(0)

3 Study Group on Peripartum Cardiomyopathy Aims To establish a platform where current knowledge on peripartum cardiomyopathy based on experimental and clinical studies is summarized and regularly up-dated. To raise awareness of this uncommon but devastating problem by promoting sessions at congresses and publishing articles. To coordinate the collection and analysis of data internationally for better understanding of the condition. To meet regularly to discuss and update management strategies with a focus on novel diagnostic and therapeutic approaches. To provide information and contact addresses on our webpage for physicians and patients concerned about PPCM. To initiate and be advocates for the PPCM Registry Karen Sliwa (Cape Town, South Africa) Burkert Pieske (Graz, AT) Denise Hilfiker-Kleiner (Hannover, DE) John McMurray (Glasgow, GB) Alexandre Mebazaa (Paris, FR) Mark Petrie (Glasgow, GB) Vera Regitz-Zagrosek (Berlin, DE) Maria Schaufelberger (Gothenburg, SE) Petar Seferovic (Belgrade, RS) Ajay Shah (London, GB) Luigi Tavazzi (Cotignola, IT) Dirk van Veldhuisen (Groningen, NL) Karin van Spaendonck-Zwart (Amsterdam, NL) Uri Elkayam (Los Angeles, US) Frederic Mouquet (Lille, FR) Katrin Bachelier-Walenta (Hamburg, DE) Affilate member: Amam Mbakwem (Nigeria)

4 Background on PPCM Registry Study Group highlighted in the Position Paper, published 2010, the lack of data from ESC member countries

5 EuroObs PPCM Registry PROOFS - in press

6 Peripartum Cardiomyopathy Study group members contributed to new knowledge advancing the understanding of the disease MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy Julie Halkein, Sebastien P. Tabruyn, Karen Sliwa, Denise Hilfiker-Kleiner,Ingrid Struman et al April 2013 The Journal of Clinical Investigation. More information at

7 ESC HFA PPCM Registry Start: May 2012 Aim: 1000 patients European Society of Cardiology Members Countries Background 1. Proposal for a PPCM Registry was submitted in Protocol finalized and start of Registry in May Recruitment status as of February 2014: 145 patients

8 PPCM Registry The electronic Case Report Form can be accessed through the website of the EURObservational Research Programme (EORP): To register and obtain login codes to access the EORP website, please contact the EORP department: The front page contain the mandatory key questions qualifying a patient as potential PPCM: 1. Peripartum stage 2. Signs and/ or symptoms of heart failure 3. Ejection fraction <45% 4. Other causes of heart failure excluded This will ensure that mainly patients with suspected PPCM will be entered.

9 Peripartum Cardiomyopathy Registry Recruitment status as of February 10 th, participating centres across 42 countries At least 1 patient enrolled No patient enrolled so far (Centres awaiting EC approval and/or patients with PPCM)

10 . Peripartum Cardiomyopathy Registry Progression of recruitment as of February 10 th, patients enrolled active centres 93 participating centres

11 Peripartum Cardiomyopathy Registry Recruitment status as of February 10 th, Patients Enrolled by 43 Active Centres across 27 Countries Patients Enrolled 120 Patients Completed 48 Patients Locked

12 . Peripartum Cardiomyopathy Registry Baseline Characteristics (1/2) Item N All n ESC n Non ESC Age 30.7±0.6 Median=30.2 Q1=25.2, Q3= ±0.8 Median=30.2 Q1=24.7, Q3= ±1.0 Median=30.3 Q1=25.8, Q3=35.3 Parity: Gravida 3.4± ± ±0.3 Parity: Para 3.0± ± ±0.3 Heart Rate (ECG) 104.1± ± ±2.8 Systolic Blood Pressure (mmhg) 119.9± ± ±4.2 Diastolic Blood Pressure (mmhg) 76.9± ± ±2.6 Left Ventricular End Systolic dimension (mm) Left Ventricular End Diastolic dimension (mm) Ejection fraction 1. Teichholz (EF1) - % Ejection fraction 2. Visual estim. (EF2) - % 51.0± ± ± ± ± ± ± ± ± ± ± ±1.8 Haemoglobin (g/dl) 11.6± ± ±0.4

13 . Peripartum Cardiomyopathy Registry Baseline Characteristics (2/2) Item n All % n ESC % N Non ESC % Diabetic Smoking Current + Former HIV status YES HIV status Unknown Hypertension during current pregnancy: Yes Hypertension during current pregnancy: Unknown Pre-eclampsia: Yes Pre-eclampsia: Unknown NYHA class I and II NYHA class III and IV Dyspnea S3 gallop JVP(>6cm) Mitral regurgitation Beta-blockers ( pre-diagnosis) Bromocriptine drugs ( pre-diagnosis) Diuretics oral ( pre-diagnosis)

14 . Peripartum Cardiomyopathy Registry Most frequent queries PAGE SECTION QUERIES 2.1. Physical Indications Heart Rate value is missing Blood Pressure systolic and diastolic are missing Investigation 2.2. Basic Information Doppler Diastolic Function Assessment QRS-duration: value not reported Intra ventricular septum systole dimension: value is missing Ejection fraction 2 visual estimation (EF2): value is missing Outcome 2.3. Chemistry Blood Sample 5.2. Conditions PPCM diagnosis 5.3. Neonate details Platelets: check units! When was the diagnosis of PPCM made: (x) should be between 6 months before Visit date and 6 months after Visit date (y) Head circumference: value is missing & unavailable Length of the neonate: value is missing & unavailable Agpar score at 5 min: value is missing & unavailable

15 Peripartum Cardiomyopathy Creating awareness for the condition and the registry Promoting the registry via lectures given Referring to the PPCM Registry in publications Interested talking part in the PPCM or ROPAC Registry? Please join us at meeting pm Please enter cases and complete the Follow Up pages at 6 Month and One Year!!!

Peripartum cardiomyopathy: Challenges and perspectives

Peripartum cardiomyopathy: Challenges and perspectives Prof. Petar M. Seferović, MD, PhD, FESC, FESC Board member, Heart Failure Association of the ESC Peripartum cardiomyopathy: Challenges and perspectives Director, Department of Cardiology, Clinical Center

More information

Update on mechanisms of peripartum cardiomyopathy: New Heart Failure Association working group position statement

Update on mechanisms of peripartum cardiomyopathy: New Heart Failure Association working group position statement Update on mechanisms of peripartum cardiomyopathy: New Heart Failure Association working group position statement Denise Hilfiker-Kleiner Kardiologie & Angiologie MHH, Hannover I have nothing to declare.

More information

Peripartum Cardiomyopathy

Peripartum Cardiomyopathy Peripartum Cardiomyopathy Denise Hilfiker-Kleiner Kardiologie & Angiologie MHH, Hannover Nothing to disclose Peri- or Postpartum Cardiomyopathy Peri- or postpartum cardiomyopathy (PPCM) is a disorder of

More information

Risk of Subsequent Pregnancy in Women with a History of Peripartum Cardiomyopathy Uri Elkayam, MD

Risk of Subsequent Pregnancy in Women with a History of Peripartum Cardiomyopathy Uri Elkayam, MD Risk of Subsequent Pregnancy in Women with a History of Peripartum Cardiomyopathy Uri Elkayam, MD Professor of Medicine / Cardiology Professor of Obstetrics and Gynecology University of Southern California

More information

Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy

Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy European Journal of Heart Failure (2012) 14, 895 901 doi:10.1093/eurjhf/hfs070 Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy Murat Biteker 1

More information

Ventricular tachyarrhythmia during pregnancy in women with heart disease: data from the ROPAC

Ventricular tachyarrhythmia during pregnancy in women with heart disease: data from the ROPAC Ventricular tachyarrhythmia during pregnancy in women with heart disease: data from the ROPAC Ebru Ertekin MD, Iris M. Van Hagen MD, Amar M. Salam MD, Titia P.E. Ruys MD PhD, Jolien W. Roos-Hesselink MD

More information

Familial Aggregation of Dilated Cardiomyopathy in Patients with Peripartum Cardiomyopathy

Familial Aggregation of Dilated Cardiomyopathy in Patients with Peripartum Cardiomyopathy Familial Aggregation of Dilated Cardiomyopathy in Patients with Peripartum Cardiomyopathy Tibazarwa K 1, Sliwa K 1, Wonkam A 2, Mayosi BM 1 1 Hatter Cardiovascular Research Institute, Department of Medicine,

More information

Diagnosis, treatment and outcome of acute heart failure in Africa Results of the THESUS-HF study

Diagnosis, treatment and outcome of acute heart failure in Africa Results of the THESUS-HF study Diagnosis, treatment and outcome of acute heart failure in Africa Results of the THESUS-HF study A. Damasceno, A. Dzudie, A. Suliman, BA Abdou, C. Mondo, O. Ogah, M. Sani, DB. Weatherly, N. Schrueder,

More information

Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi.

Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi. Appropriateness of prescriptions of recommended treatments in OECD health systems: findings based on the Long-Term Registry of the ESC on Heart Failure Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato

More information

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Dr. Antonio Magaña M.D. (on behalf I-PREFER investigators group) Stockholm, Sweden, August

More information

Diagnosis is it really Heart Failure?

Diagnosis is it really Heart Failure? ESC Congress Munich - 25-29 August 2012 Heart Failure with Preserved Ejection Fraction From Bench to Bedside Diagnosis is it really Heart Failure? Prof. Burkert Pieske Department of Cardiology Med.University

More information

Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy

Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy Yaméogo et al. BMC Cardiovascular Disorders (2018) 18:119 https://doi.org/10.1186/s12872-018-0856-7 RESEARCH ARTICLE Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum

More information

VALVULAR HEART DISEASE AND PULMONARY CIRCULATION

VALVULAR HEART DISEASE AND PULMONARY CIRCULATION ESC CONGRESS HIGHLIGHTS VALVULAR HEART DISEASE AND PULMONARY CIRCULATION N. Ajmone Marsan (Leiden, NL) MD, PhD, FESC Conflicts of Interest None CONTENTS Pulmonary arterial hypertension Rheumatic heart

More information

BSH Annual Autumn Meeting 2017

BSH Annual Autumn Meeting 2017 BSH Annual Autumn Meeting 2017 Presentation title: The Development of CRT Speaker: John GF Cleland Conflicts of interest: I have received research support and honoraria from Biotronik, Boston Scientific,

More information

Background The EURObservational Research Programme is a rolling programme of cardiovascular registries and surveys of the

Background The EURObservational Research Programme is a rolling programme of cardiovascular registries and surveys of the European Journal of Heart Failure (2014) 16, 583 591 doi:10.1002/ejhf.68 EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure

More information

The Hearth Rate modulators. How to optimise treatment

The Hearth Rate modulators. How to optimise treatment The Hearth Rate modulators How to optimise treatment Munich, ESC Congress 2012 Prof. Luigi Tavazzi GVM Care&Research E.S. Health Science Foundation Cotignola, IT Disclosure Cooperation with: Servier, Medtronic,

More information

Bromocriptine for the treatment of PPCM A multicenter, randomized study. Results and Implication

Bromocriptine for the treatment of PPCM A multicenter, randomized study. Results and Implication Bromocriptine for the treatment of PPCM A multicenter, randomized study Results and Implication Denise Hilfiker-Kleiner Kardiologie & Angiologie MHH, Hannover Funding by DFG Excellence Cluster REBIRTH

More information

Susan P. D Anna MSN, APRN BC February 14, 2019

Susan P. D Anna MSN, APRN BC February 14, 2019 Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with

More information

Considerations on Phasing Out Medications In the Treatment of Peripartum Cardiomyopathy After Full Recovery James D. Fett, MD

Considerations on Phasing Out Medications In the Treatment of Peripartum Cardiomyopathy After Full Recovery James D. Fett, MD Considerations on Phasing Out Medications In the Treatment of Peripartum Cardiomyopathy After Full Recovery James D. Fett, MD Co-Director, Peripartum Cardiomyopathy Network, Coordinating Center, University

More information

Pregnancy and Heart Disease

Pregnancy and Heart Disease Pregnancy and Heart Disease Heidi M. Connolly, MD No disclosures 2011 MFMER 3138928-1 Regitz-Zagrosek V, Lundqvist C, Borghi C, et al. Pregnancy and the Heart 2% of pregnancies involve maternal CV disease

More information

The variable clinical course of peripartum cardiomyopathy

The variable clinical course of peripartum cardiomyopathy The variable clinical course of peripartum cardiomyopathy Jan Krejci a, Petr Hude a, Lenka Spinarova a, Vita Zampachova b, Alzbeta Sirotkova b, Tomas Freiberger c, Eva Nemcova c, Jiri Vitovec a Background.

More information

Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study

Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study ORIGINAL RESEARCH ARTICLE ESC HEART FAILURE Published online 30 September 2015 in Wiley Online Library (wileyonlinelibrary.com) Prognostic implication of right ventricular involvement in peripartum cardiomyopathy:

More information

ESSENTIAL MESSAGES FROM ESC GUIDELINES

ESSENTIAL MESSAGES FROM ESC GUIDELINES ESSENTIAL MESSAGES FROM ESC GUIDELINES Committee for Practice Guidelines To improve the quality of clinical practice and patient care in Europe HCM GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC

More information

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction The Prospective comparison of ARNI with ARB on Management Of heart failure with preserved ejection

More information

What to do when a heart failure patient becomes pregnant

What to do when a heart failure patient becomes pregnant BSH Heart Failure Day for Revalidation and Training 2017 What to do when a heart failure patient becomes pregnant Dr Diane Barker Consultant Cardiologist Royal Stoke Hospital Conflicts of interest - sponsorship,

More information

Update on pharmacological treatment of heart failure. Aldo Pietro Maggioni, MD, FESC ANMCO Research Center Firenze, Italy

Update on pharmacological treatment of heart failure. Aldo Pietro Maggioni, MD, FESC ANMCO Research Center Firenze, Italy Update on pharmacological treatment of heart failure Aldo Pietro Maggioni, MD, FESC ANMCO Research Center Firenze, Italy Presenter Disclosures Dr. Maggioni : Serving in Committees of studies sponsored

More information

Angiogenic imbalance and residual myocardial dysfunction in women with Peripartum Cardiomyopathy and left ventricular function recovery

Angiogenic imbalance and residual myocardial dysfunction in women with Peripartum Cardiomyopathy and left ventricular function recovery Angiogenic imbalance and residual myocardial dysfunction in women with Peripartum Cardiomyopathy and left ventricular function recovery Sorel Goland¹, Adi Zalik¹, Jan Mark Weinstein³, Liaz Zilberman¹,

More information

Right Ventricular Systolic Dysfunction is common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa

Right Ventricular Systolic Dysfunction is common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa Right Ventricular Systolic Dysfunction is common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa 1 Ojji Dike B, Lecour Sandrine, Atherton John J, Blauwet Lori A, Alfa Jacob, Sliwa

More information

Take-home Messages from Recent Heart Failure Trials: Heart Rate as a Target

Take-home Messages from Recent Heart Failure Trials: Heart Rate as a Target Take-home Messages from Recent Heart Failure Trials: Heart Rate as a Target JEFFREY S. BORER, M.D. Professor and Chairman, Department of Medicine and Chief, Division of Cardiovascular Medicine; Director,

More information

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study European Heart Journal (2017) 38, 2671 2679 doi:101093/eurheartj/ehx355 CLINICAL RESEARCH Heart failure/cardiomyopathy Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized

More information

New in Heart Failure SGK autumn session 2012

New in Heart Failure SGK autumn session 2012 New in Heart Failure SGK autumn session 2012 Roger Hullin Cardiology Department of Internal Medicine Centre Universitaire Hospitaler Vaudois University of Lausanne ESC Heart Failure Guidelines 2012 Classes

More information

PCHF. A novel course in heart failure management POSTGRADUATE COURSE IN HEART FAILURE

PCHF. A novel course in heart failure management POSTGRADUATE COURSE IN HEART FAILURE PCHF POSTGRADUATE COURSE IN HEART FAILURE A novel course in heart failure management Certified by the European Society of Cardiology (ESC) and the University of Zurich. Based on the new curriculum of the

More information

Opening Ceremony. Opening Lecture: Cardiovascular physiology of pregnancy and the puerperium Uri Elkayam University of Southern California, USA

Opening Ceremony. Opening Lecture: Cardiovascular physiology of pregnancy and the puerperium Uri Elkayam University of Southern California, USA Opening Ceremony Greetings Opening Lecture, CPP 2018 Congress chairman Opening Lecture: Cardiovascular physiology of pregnancy and the puerperium Echocardiographic changes in normal pregnancy Joan Briller

More information

Introduction POSITION STATEMENT

Introduction POSITION STATEMENT European Journal of Heart Failure (2010) 12, 767 778 doi:10.1093/eurjhf/hfq120 POSITION STATEMENT Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy:

More information

The ESC Registry on Chronic Ischemic Coronary Disease

The ESC Registry on Chronic Ischemic Coronary Disease EURObservational Research Programme The ESC Registry on Chronic Ischemic Coronary Disease Prof. Fausto J. Pinto, FESC, FACC, FASE, FSCAI Immediate Past-President, ESC University Hospital Sta Maria University

More information

Use of bromocriptine for the treatment of PPCM: are we there yet?

Use of bromocriptine for the treatment of PPCM: are we there yet? Use of bromocriptine for the treatment of PPCM: are we there yet? Uri Elkayam, MD Professor of Medicine Professor of Obstetrics and Gynecology Director maternal cardiology University of Southern California

More information

Acute heart failure, beyond conventional treatment: persisting low output

Acute heart failure, beyond conventional treatment: persisting low output Acute heart failure, beyond conventional treatment: persisting low output Alexandre Mebazaa, FESC Hôpital Lariboisière, Université Paris 7 U942 Inserm Conflict of Interest Lecture fee: Orion No other conflicts

More information

Euro Heart Survey New Programme Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI

Euro Heart Survey New Programme Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI Euro Heart Survey New Programme 2009-2012 Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI Alan Cribier, Rouen, France Andreas Gruentzig Award 2010 Cardiogenic

More information

PCHF A NOVEL COURSE IN HEART FAILURE MANAGEMENT POSTGRADUATE COURSE IN HEART FAILURE LONDON. January 2019 to October 2020

PCHF A NOVEL COURSE IN HEART FAILURE MANAGEMENT POSTGRADUATE COURSE IN HEART FAILURE LONDON. January 2019 to October 2020 PCHF POSTGRADUATE COURSE IN HEART FAILURE LONDON A NOVEL COURSE IN HEART FAILURE MANAGEMENT January 2019 to October 2020 Venue: The Royal Society of Medicine, 1 Wimpole Street, Marylebone, London, UK Endorsed

More information

Peripartum Cardiomyopathy. Lavanya Rai Manipal

Peripartum Cardiomyopathy. Lavanya Rai Manipal Peripartum Cardiomyopathy Lavanya Rai Manipal Definition - PPCM - Dilated cardiomyopathy of unknown cause resulting in cardiac failure that occurs in the peripartum period in women without any preexisting

More information

The Approach to Patients with Heart Failure and Mid-Range (40-50%) Ejection Fraction (HFmrEF)

The Approach to Patients with Heart Failure and Mid-Range (40-50%) Ejection Fraction (HFmrEF) The Approach to Patients with Heart Failure and Mid-Range (40-50%) Ejection Fraction (HFmrEF) 22 nd Annual Heart Failure 2018 an Update on Therapy April 21, 2018 Los Angeles, CA Barry Greenberg, M.D. Distinguished

More information

Copeptin in heart failure: Associations with clinical characteristics and prognosis

Copeptin in heart failure: Associations with clinical characteristics and prognosis Copeptin in heart failure: Associations with clinical characteristics and prognosis D. Berliner, N. Deubner, W. Fenske, S. Brenner, G. Güder, B. Allolio, R. Jahns, G. Ertl, CE. Angermann, S. Störk for

More information

Mihai Gheorghiade MD

Mihai Gheorghiade MD Mihai Gheorghiade MD Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Illinois On behalf of: Stephen J Greene MD; Javed Butler MD MPH MBA; Gerasimos Filippatos

More information

Peripartum cardiomyopathy: Frequency and predictors and indicators of clinical outcome

Peripartum cardiomyopathy: Frequency and predictors and indicators of clinical outcome 1517 ORIGINAL ARTICLE Peripartum cardiomyopathy: Frequency and predictors and indicators of clinical outcome Shakira Perveen, 1 Jahanara Ainuddin, 2 Shazia Jabbar, 3 Khalida Soomro, 4 Arif Ali 5 Abstract

More information

Address: Dept of Medicine, College of Medicine, university of Lagos, PMB Lagos, Idi Araba, Lagos Nigeria

Address: Dept of Medicine, College of Medicine, university of Lagos, PMB Lagos, Idi Araba, Lagos Nigeria CURRICULUM VITAE. MBBS, FWACP, FACC, FESC. Professor Amam C. Mbakwem. Gender: Female Place and date: Port Harcourt / 6 th March 1957 Address: Dept of Medicine, College of Medicine, university of Lagos,

More information

Congestive Heart Failure or Heart Failure

Congestive Heart Failure or Heart Failure Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?

More information

ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy

ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy Task force on the management of CVD during pregnancy of the ESC Chair: Vera Regitz-Zagrosek, Charite, Berlin None DECLARATION

More information

C. Lutman, L. Vitali Serdoz, G. Barbati, E. Cadamuro, S. Magnani, M. Zecchin, M. Merlo, G. Sinagra

C. Lutman, L. Vitali Serdoz, G. Barbati, E. Cadamuro, S. Magnani, M. Zecchin, M. Merlo, G. Sinagra C. Lutman, L. Vitali Serdoz, G. Barbati, E. Cadamuro, S. Magnani, M. Zecchin, M. Merlo, G. Sinagra Cardiovascular Department, Ospedali Riuniti and University, Trieste, Italy PURPOSE Sex differences exist

More information

Heart Failure with Preserved EF (HFPEF) Epidemiology and management

Heart Failure with Preserved EF (HFPEF) Epidemiology and management Heart Failure with Preserved EF (HFPEF) Epidemiology and management Karl Swedberg Senior Professor of Medicine Sahlgrenska Academy University of Gothenburg Gothenburg, Sweden e-mail: karl.swedberg@gu.se

More information

ESSENTIAL MESSAGES FROM

ESSENTIAL MESSAGES FROM ESSENTIAL MESSAGES FROM ESC GUIDELINES Committee for Practice Guidelines To improve the quality of clinical practice and patient care in Europe VHD ESC/EACTS Guidelines ON the Management OF VALVULAR HEART

More information

Saudi Arabia February Pr Michel KOMAJDA. Université Pierre et Marie Curie Hospital Pitié Salpétrière

Saudi Arabia February Pr Michel KOMAJDA. Université Pierre et Marie Curie Hospital Pitié Salpétrière Prevention of Cardiovascular events with Ivabradine: The SHIFT Study Saudi Arabia February 2011 Pr Michel KOMAJDA Université Pierre et Marie Curie Hospital Pitié Salpétrière Paris FRANCE Declaration Of

More information

What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE. Marc Ferrini (Lyon Fr)

What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE. Marc Ferrini (Lyon Fr) What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE Marc Ferrini (Lyon Fr) Palermo (I) 1 04 2017 Consulting Fees, Honoraria: BAYER PHARMA BOEHRINGER INGELHEIM BRISTOL MEYERS

More information

Heart Failure. GP Update Refresher 18 th January 2018

Heart Failure. GP Update Refresher 18 th January 2018 GP Update Refresher 18 th January 2018 Heart Failure Dr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK President of British

More information

Pan American Heart Failure Congress (PAHF 2012) October 18 th -21 th 2012 Panama City, Panama

Pan American Heart Failure Congress (PAHF 2012) October 18 th -21 th 2012 Panama City, Panama Pan American Heart Failure Congress (PAHF 2012) October 18 th -21 th 2012 Panama City, Panama Congress Chairman Uri Elkayam, MD Professor of Medicine University of Southern California, Keck School of Medicine

More information

Disclosures. Advances in Chronic Heart Failure Management 6/12/2017. Van N Selby, MD UCSF Advanced Heart Failure Program June 19, 2017

Disclosures. Advances in Chronic Heart Failure Management 6/12/2017. Van N Selby, MD UCSF Advanced Heart Failure Program June 19, 2017 Advances in Chronic Heart Failure Management Van N Selby, MD UCSF Advanced Heart Failure Program June 19, 2017 I have nothing to disclose Disclosures 1 Goal statement To review recently-approved therapies

More information

Selective Cardiac Myosin Activators in Heart Failure

Selective Cardiac Myosin Activators in Heart Failure Selective Cardiac Myosin Activators in Heart Failure John McMurray Eugene Braunwald Scholar in Cardiovascular Diseases, Brigham and Women s Hospital, Boston & Visiting Professor, Harvard Medical School

More information

Working Group on: Grown-up Congenital Heart Disease (GUCH)

Working Group on: Grown-up Congenital Heart Disease (GUCH) Working Group on: Grown-up Congenital Heart Disease (GUCH) Annual Report 2007-2008 The Nucleus composition for 2008-10: Chairperson: Folkert Meijboom (NL) Vice-chairperson: Pedro Trigo Trindade (CH) Past

More information

Management of Heart Failure and Cardiomyopathies in Pregnancy

Management of Heart Failure and Cardiomyopathies in Pregnancy Management of Heart Failure and Cardiomyopathies in Pregnancy Professor Sanjay Sharma Disclosures: None Epidemiology of Cardiac Disease In Pregnancy Cardiovascular disease in pregnancy is increasing in

More information

Iron Deficiency: New Therapeutic Target in Heart Failure. Stefan D. Anker, MD PhD

Iron Deficiency: New Therapeutic Target in Heart Failure. Stefan D. Anker, MD PhD Iron Deficiency: New Therapeutic Target in Heart Failure Stefan D. Anker, MD PhD Department of Cardiology, Applied Cachexia Research, Charité Campus Virchow-Klinikum, Universitätsmedizin Berlin, Germany.

More information

Pregnancy and Heart Disease. Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital

Pregnancy and Heart Disease. Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital Pregnancy and Heart Disease Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital Pregnancy is not a state Hemodynamic changes During pregnancy Estrogens 1. Renin 2.

More information

POSTGRADUATE COURSE IN HEART FAILURE A NOVEL COURSE IN HEART FAILURE MANAGEMENT

POSTGRADUATE COURSE IN HEART FAILURE A NOVEL COURSE IN HEART FAILURE MANAGEMENT PCHF POSTGRADUATE COURSE IN HEART FAILURE 3 rd Edition A NOVEL COURSE IN HEART FAILURE MANAGEMENT January 2018 to October 2019 University Hospital Zurich, Switzerland Brussels, Belgium Endorsed by the

More information

Reversible peripartum cardiomyopathy in a triplet pregnancy

Reversible peripartum cardiomyopathy in a triplet pregnancy Reversible peripartum cardiomyopathy in a triplet pregnancy BY EDVARD GALIĆ, DARIO GULIN, KREŠIMIR KORDIĆ, BERIVOJ MIŠKOVIĆ, OLIVER VASILJ, JOZICA ŠIKIĆ Abstract Peripartum cardiomyopathy (PPCM) is a rare

More information

Effect of ferric carboxymaltose on functional capacity in patients with heart failure and iron deficiency (CONFIRM-HF)

Effect of ferric carboxymaltose on functional capacity in patients with heart failure and iron deficiency (CONFIRM-HF) Effect of ferric carboxymaltose on functional capacity in patients with heart failure and iron deficiency (CONFIRM-HF) Piotr Ponikowski, Dirk J. van Veldhuisen, Josep Comin-Colet Georg Ertl, Michel Komajda,

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response

More information

HEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida

HEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida HEART FAILURE IN WOMEN Marian Limacher, MD Division of Cardiovascular Medicine University of Florida Outline Epidemiology Clinical Overview Why HF is such a challenge State of the Field Heart Failure Adjudication

More information

Online Appendix (JACC )

Online Appendix (JACC ) Beta blockers in Heart Failure Collaborative Group Online Appendix (JACC013117-0413) Heart rate, heart rhythm and prognostic effect of beta-blockers in heart failure: individual-patient data meta-analysis

More information

PROCORALAN MAKING A STRONG ENTRY TO THE NEW ESC GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE

PROCORALAN MAKING A STRONG ENTRY TO THE NEW ESC GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE Press Release Issued on behalf of Servier Date: June 6, 2012 PROCORALAN MAKING A STRONG ENTRY TO THE NEW ESC GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE The new ESC guidelines for the diagnosis and

More information

Peripartum cardiomyopathy: review and practice guidelines. Hanan ALBackr Associate Professor King Saud university, King Fahad Cardaic center -Riyadh

Peripartum cardiomyopathy: review and practice guidelines. Hanan ALBackr Associate Professor King Saud university, King Fahad Cardaic center -Riyadh Peripartum cardiomyopathy: review and practice guidelines Hanan ALBackr Associate Professor King Saud university, King Fahad Cardaic center -Riyadh Outlines Definition of PPCM Dignostic Critaria for peripartum

More information

Diastolic Heart Failure Uri Elkayam, MD

Diastolic Heart Failure Uri Elkayam, MD Diastolic Heart Failure Uri Elkayam, MD Professor of Medicine University of Southern California School of Medicine Los Angeles, California elkayam@usc.edu Diastolic Heart Failure Clinical Definition A

More information

Heart failure: what should be changed? Prof. Gerasimos Filippatos Attikon University Hospital

Heart failure: what should be changed? Prof. Gerasimos Filippatos Attikon University Hospital Heart failure: what should be changed? Prof. Gerasimos Filippatos Attikon University Hospital Disclosures Chair or Committee Member of trials or registries sponsored by Novartis, Bayer, Cardiorentis, Servier

More information

HEART FAILURE VIENNA

HEART FAILURE VIENNA HEART FAILURE: GUIDELINES, CONSENSUS STATEMENTS, TRIAL RESULTS, AND MORE Petar M. Seferovic, MD, PhD, FESC, FACC Author affiliations: President of the Heart failure Association of the ESC; Corresponding

More information

The ACC 50 th Annual Scientific Session

The ACC 50 th Annual Scientific Session Special Report The ACC 50 th Annual Scientific Session Part One From March 18 to 21, 2001, physicians from around the world gathered to learn, to teach and to discuss at the American College of Cardiology

More information

Gender differences in clinical characteristics and outcome of acute heart failure in sub-saharan Africa: results of the THESUS-HF study

Gender differences in clinical characteristics and outcome of acute heart failure in sub-saharan Africa: results of the THESUS-HF study DOI 10.1007/s00392-015-0810-y ORIGINAL PAPER Gender differences in clinical characteristics and outcome of acute heart failure in sub-saharan Africa: results of the THESUS-HF study Okechukwu S. Ogah Beth

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome

Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome G. Deswarte, AS. Polge, N. Lamblin, A. Millaire, M. Richardson, C. Bauters,

More information

Is it HF secondary to rheumatic heart disease???

Is it HF secondary to rheumatic heart disease??? Is it HF secondary to rheumatic heart disease??? Is mitral regurg. Is complication of CHF??? Cardiomyopathy Definition The term cardiomyopathy is purely descriptive, meaning disease of the heart muscle

More information

Innovation therapy in Heart Failure

Innovation therapy in Heart Failure Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure

More information

Maternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital

Maternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 19 Number 1 Maternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital

More information

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling

More information

Effects of heart rate reduction with ivabradine on left ventricular remodeling and function:

Effects of heart rate reduction with ivabradine on left ventricular remodeling and function: Systolic Heart failure treatment with the If inhibitor ivabradine Trial Effects of heart rate reduction with ivabradine on left ventricular remodeling and function: results of the SHIFT echocardiography

More information

SESSION D5. The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM

SESSION D5. The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM 37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION D5 Session Description: The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM

More information

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes Cardiovasc Drugs Ther (2017) 31:545 549 DOI 10.1007/s10557-017-6754-x ORIGINAL ARTICLE Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes

More information

Mechanisms of False Positive Exercise Electrocardiography: Is False Positive Test Truly False?

Mechanisms of False Positive Exercise Electrocardiography: Is False Positive Test Truly False? Mechanisms of False Positive Exercise Electrocardiography: Is False Positive Test Truly False? Masaki Izumo a, Kengo Suzuki b, Hidekazu Kikuchi b, Seisyo Kou b, Keisuke Kida b, Yu Eguchi b, Nobuyuki Azuma

More information

Effects of heart rate reduction with ivabradine on left ventricular remodeling and function:

Effects of heart rate reduction with ivabradine on left ventricular remodeling and function: Systolic Heart failure treatment with the If inhibitor ivabradine Trial Effects of heart rate reduction with ivabradine on left ventricular remodeling and function: results of the SHIFT echocardiography

More information

Report on the Expert Group Meeting of Paediatric Heart Failure, London 29 November 2010

Report on the Expert Group Meeting of Paediatric Heart Failure, London 29 November 2010 Report on the Expert Group Meeting of Paediatric Heart Failure, London 29 November Clinical trials in Paediatric Heart Failure List of participants: Michael Burch, Hugo Devlieger, Angeles Garcia, Daphne

More information

12 th Annual Biomarkers in Heart Failure and Acute Coronary Syndromes: Diagnosis, Treatment and Devices. Heart Rate as a Cardiovascular Biomarker

12 th Annual Biomarkers in Heart Failure and Acute Coronary Syndromes: Diagnosis, Treatment and Devices. Heart Rate as a Cardiovascular Biomarker 12 th Annual Biomarkers in Heart Failure and Acute Coronary Syndromes: Diagnosis, Treatment and Devices Heart Rate as a Cardiovascular Biomarker Inder Anand, MD, FRCP, D Phil (Oxon.) Professor of Medicine,

More information

Cardiac disease as a cause of maternal mortality in Europe

Cardiac disease as a cause of maternal mortality in Europe Cardiac Problems in Pregnancy, Las Vegas, 2016 Risk prediction and maternal mortality Cardiac disease as a cause of maternal mortality in Europe (Els) Petronella G Pieper University Medical Centre Groningen

More information

Update on peripartum cardiomyopathy: Pathophysiology

Update on peripartum cardiomyopathy: Pathophysiology Update on peripartum cardiomyopathy: Pathophysiology I HAVE NOTHING TO DISCLOSE Denise Hilfiker-Kleiner Kardiologie & Angiologie MHH, Hannover Peri- or Postpartum Cardiomyopathy Peri- or postpartum cardiomyopathy

More information

Clinical Outcomes of Women with Peripartum Cardiomyopathy With and Without Preeclampsia: a Population-based Study

Clinical Outcomes of Women with Peripartum Cardiomyopathy With and Without Preeclampsia: a Population-based Study Clinical Outcomes of Women with Peripartum Cardiomyopathy With and Without Preeclampsia: a Population-based Study Isabelle Malhamé, MSc Candidate in Epidemiology, McGill University Obstetric Medicine Fellow,

More information

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart

More information

National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008

National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008 Irbesartan (Aprovel) for heart failure with preserved systolic function August 2008 This technology summary is based on information available at the time of research and a limited literature search. It

More information

Journal of the American College of Cardiology Vol. 52, No. 24, by the American College of Cardiology Foundation ISSN /08/$34.

Journal of the American College of Cardiology Vol. 52, No. 24, by the American College of Cardiology Foundation ISSN /08/$34. Journal of the American College of Cardiology Vol. 52, No. 24, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.09.011

More information

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:

More information

Catherine Nelson-Piercy. Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK

Catherine Nelson-Piercy. Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK Cardiac Disease and Pregnancy Catherine Nelson-Piercy Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK Physiological changes in pregnancy Cardiac Output (CO) increases by 40% Further

More information

Heart Failure treatment during pregnancy

Heart Failure treatment during pregnancy Heart Failure treatment during pregnancy Angeles Alonso García Hospital Universitario Puerta de Hierro. Majadahonda. Madrid. Spain European Society of Cardiology. Stockholm. 29 August 2010 Starting Point

More information

Aldosterone Antagonism in Heart Failure: Now for all Patients?

Aldosterone Antagonism in Heart Failure: Now for all Patients? Aldosterone Antagonism in Heart Failure: Now for all Patients? Inder Anand, MD, FRCP, D Phil (Oxon.) Professor of Medicine, University of Minnesota, Director Heart Failure Program, VA Medical Center 111C

More information

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 1 Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 DISCLOSURES I have no disclosures relevant to today s talk 2 Cardiovascular Effects of Pregnancy Anatomic Ventricular muscle mass increases

More information

Peripartum management of Rheumatic Heart Disease

Peripartum management of Rheumatic Heart Disease Peripartum management of Rheumatic Heart Disease Dr James Sartain Director of Anaesthesia & Perioperative Medicine Cairns & Hinterland Hospital & Health Service Talk outline Why (still) talk about RHD

More information